| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 11/13/2008 | US20080281352 Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers |
| 11/13/2008 | US20080281298 Electronic support system for biological data sensor |
| 11/13/2008 | US20080281273 Microneedle transdermal transport device |
| 11/13/2008 | US20080281084 Using charged polymers to enhance solubility of polypeptide in aqueous solutions |
| 11/13/2008 | US20080280993 Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine |
| 11/13/2008 | US20080280984 Transdermal Delivery of Beneficial Substances Effected By a Hostile Biophysical Environment |
| 11/13/2008 | US20080280958 Administering a phosphodiesterase inhibitor; bioavailability; skin disorders; respiratory system disorders; using roflumilast |
| 11/13/2008 | US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus |
| 11/13/2008 | US20080279963 Aqueous isotonic solution of hypohalous acid and halide salt; acidity pH; storage stability; active against three types of Staphlococcus |
| 11/13/2008 | US20080279955 Pharmaceutical microparticles |
| 11/13/2008 | US20080279954 Drug delivery; therapeutic agent and crosslinked polymer network |
| 11/13/2008 | US20080279953 Methods of producing stable pancreatic enzyme compositions |
| 11/13/2008 | US20080279952 Controlling particle size; overcoating particles; pain therapy eith postoperative or tumor pain; central nervous system disorders; antiepileptic agents; Parkinson's disease; longQT syndrome; potassium channel moderators; muscular disorders; prion disease; Alzheimer's disease; tinnitus ; overactive bladde |
| 11/13/2008 | US20080279951 Stable Oral Benzimidazole Compositions Prepared by Non-Aqueous Layering Process |
| 11/13/2008 | US20080279950 Nano-particles comprising cucurbituril derivatives, pharmaceutical composition containing the same, and process for the preparation thereof |
| 11/13/2008 | US20080279949 Such as paclitaxel and stabilizer |
| 11/13/2008 | US20080279948 Treatment of Asthma and Copd Using Triple-Combination Therapy |
| 11/13/2008 | US20080279947 Menthol-Containing Solids Composition |
| 11/13/2008 | US20080279946 Methods and compositions for increasing infrared absorptivity of a target |
| 11/13/2008 | US20080279945 Water soluble gel; gene expression of nucleic acid segments encoding therapy constructs including peptides, polypeptides, ribozymes and catalytic Rna to cells or tissues of animals; cardiovascular disorders; muscular dystrophy |
| 11/13/2008 | US20080279944 In situ implantable and absorbable drug delivery device capable of delivering low molecular weight material in a sustained fashion |
| 11/13/2008 | US20080279943 Gel substrate with porous surface with enhanced compatibility between it and living tissues ; spinal disk prosthetics; casting, molding polyvinyl alcohol |
| 11/13/2008 | US20080279942 Mixture with hydrophilic polymer, acid and fluidization agent; improved dissolving properties ; hypotensive agents |
| 11/13/2008 | US20080279941 Hydrogel substrate with porous surfaces; attaching biomaterials to living tissue; load bearing inserts; tissue repair and regeneration; disk prosthetics |
| 11/13/2008 | US20080279940 For treatment or prevention of chronic pain |
| 11/13/2008 | US20080279939 Using a mixture of tissue sources; regeneration in situ |
| 11/13/2008 | US20080279938 Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 11/13/2008 | US20080279937 Microencapsulation; drug coated with water soluble polymer membrane; blending crystals; compression |
| 11/13/2008 | US20080279936 Hypotensive agents; cardiovascular disorders; antiischemic agents; brain disorders; headaches; kidney disease; sustained release |
| 11/13/2008 | US20080279935 Composition Comprising a Powder Containing Microencapsulated Polyunsaturated Long-Chain Esterified Fatty Acids Distributed in an Effervescent Base |
| 11/13/2008 | US20080279934 Multilayer tablet ; autoimmune disease; antidiabetic agents; rheumatic disorders; antiarthritic agents; psoriasis |
| 11/13/2008 | US20080279933 Flurbiprofen and muscle relaxant combinations |
| 11/13/2008 | US20080279932 Vildagliptin salt; in mixture with therapeutic agents such as antidiabetic agents; antilipemic agents; obesity; appetite control; hypotensive agents; cholesterol absorption moderators; anticoagulants; estrogen receptor moderators; transferring across blood-brain barrier |
| 11/13/2008 | US20080279931 Mixture of glucosamine, devil claw, adenosylmethonine/5-/, and non-steroid antiinflamamtory drug |
| 11/13/2008 | US20080279930 Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof |
| 11/13/2008 | US20080279929 Nanoparticulate and Controlled Release Compositions Comprising Cefditoren |
| 11/13/2008 | US20080279928 Dissolving a solid in solvent; then rapidly desolventizing; controlling particle sizes |
| 11/13/2008 | US20080279927 Non-Pegylated Long-Circulating Liposomes |
| 11/13/2008 | US20080279926 Vaccine Compositions Comprising a Saponin Adjuvant |
| 11/13/2008 | US20080279925 Method(s) of preventing, arresting, reversing and treatment of atherosclerosis |
| 11/13/2008 | US20080279924 HLA class I A2 tumor associated antigen peptides and vaccine compositions |
| 11/13/2008 | US20080279923 Use of Microtubule Stabilizing Compounds for the Treatment of Lesions of Cns Axons |
| 11/13/2008 | US20080279922 Immobilization with polyoxyethylene glycol; adjust circulation half-life |
| 11/13/2008 | US20080279921 Gel-formulations of hydrophobic photosensitizers for mucosal applications |
| 11/13/2008 | US20080279920 Compositions For Treating Respiratory Viral Infections and Their Use |
| 11/13/2008 | US20080279919 Liposomes for protection against toxic compounds |
| 11/13/2008 | US20080279918 Composition charged with liposome; injecting into target cell; in vitro protein synthesis in gap between liposomes; drug delivery |
| 11/13/2008 | US20080279917 Bisbenzamidines for the Treatment of Pneumonia |
| 11/13/2008 | US20080279916 Liposome Preparation |
| 11/13/2008 | US20080279915 Matrix-Controlled Transdermal Therapeutic System Based on an Adhesive for Administering Norelgestromin or the Combination Thereof with an Estrogen |
| 11/13/2008 | US20080279914 Transdermal composition comprising piroxicam-inorganic material complex and patch system comprising the same |
| 11/13/2008 | US20080279909 Immobilized Biologically Active Entities Having A High Degree of Biological Activity Following Sterilization |
| 11/13/2008 | US20080279906 Intracellular delivery of endothelial growth factor |
| 11/13/2008 | US20080279905 Low irritation; containing ethylene-vinyl alcohol fibers and a crystal structure thermp[lastic resin |
| 11/13/2008 | US20080279900 Gel useful for the delivery of cosmetic active ingredients |
| 11/13/2008 | US20080279898 Biologically Degradable Compositions For Medical Applications |
| 11/13/2008 | US20080279815 Method for developing testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 11/13/2008 | US20080279790 Environmentally desirable for use as refrigerants, aerosol propellants, metered dose inhalers, blowing agents for polymer foam, heat transfer media, and gaseous dielectrics |
| 11/13/2008 | US20080279789 Synergistic mixture; prophylaxis and treatment of respiratory system disorders |
| 11/13/2008 | US20080279788 propellant, an effective quantity of adsorbent, a pharmaceutically active substance, substance formulation or substance mixture |
| 11/13/2008 | US20080279786 Method for Extending Lifespan Delaying the Onset of Age-Related Disease |
| 11/13/2008 | US20080279785 Novel synthetic agonists of toll-like receptors containing CG dinucleotide modifications |
| 11/13/2008 | US20080279784 Nasal administration of benzodiazepines |
| 11/13/2008 | US20080279783 Isolated nanocapsule populations and surfactant-stabilized microcapsules and nanocapsules for diagnostic imaging and drug delivery and methods for their production |
| 11/13/2008 | US20080279764 Method and composition for treating cancer |
| 11/13/2008 | US20080276935 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 11/13/2008 | US20080276568 Building structure and components thereof |
| 11/13/2008 | DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use |
| 11/13/2008 | DE102007016598A1 Drink container with heterogeneous composite or heterogeneous mixture/dispersing system consisting of drinkable viscous food as dispersing agent and pure loess/healing earth as disperse phase, comprises filling- and discharge opening |
| 11/13/2008 | CA2753209A1 Honokiol analogs and their use in treating cancers |
| 11/13/2008 | CA2687130A1 Solid dosage forms comprising an enteric coating with accelerated drug release |
| 11/13/2008 | CA2686866A1 Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 11/13/2008 | CA2686396A1 Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia |
| 11/13/2008 | CA2685956A1 A method for treating inflammation and controlled-release material capable of providing same |
| 11/13/2008 | CA2685873A1 Self-precipitating pharmaceutical formulations for the modified release of active principle |
| 11/13/2008 | CA2685855A1 Modified-release particles based on polyelectrolytes and on an active principle and pharmaceutical formulations containing these particles |
| 11/13/2008 | CA2685853A1 Composition for transmucosal delivery of polypeptides |
| 11/13/2008 | CA2685831A1 Novel pharmaceutical composition |
| 11/13/2008 | CA2685421A1 Oronasopharyngeally deliverable pharmaceutical composition for the prevention/alleviation and/or treatment of restless limb disorder |
| 11/13/2008 | CA2684173A1 Process for production of tablet |
| 11/13/2008 | CA2684126A1 Antifungal foam containing ciclopiroxolamine and zinc pyrithione, and medical and cosmetic applications thereof |
| 11/12/2008 | EP1990639A1 System and method for real-time diagnosis, treatment, and therapeutic drug monitoring |
| 11/12/2008 | EP1990062A1 Granules, tablets and method of producing the same |
| 11/12/2008 | EP1990061A2 Pharmaceutical composition for transdermal or transmucosal delivery |
| 11/12/2008 | EP1990050A1 Disinfectant ointment |
| 11/12/2008 | EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation |
| 11/12/2008 | EP1990045A1 Polysaccharide capsules and methods of preparation |
| 11/12/2008 | EP1990044A1 Mifepristone pharmaceutical compositions and their methods of preparation |
| 11/12/2008 | EP1990040A1 Nanoparticle delivery vehicle |
| 11/12/2008 | EP1988913A1 G-csf liquid formulation |
| 11/12/2008 | EP1988907A2 Compositions comprising a bisphosphonate and an antifolate |
| 11/12/2008 | EP1988904A2 Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 11/12/2008 | EP1988886A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 11/12/2008 | EP1988881A2 Oral controlled release formulation for sedative and hypnotic agents |
| 11/12/2008 | EP1988880A2 Stable mixture of corticosteroids |
| 11/12/2008 | EP1988879A1 Pro-nanodispersion for the delivery of cyclosporin |
| 11/12/2008 | EP1988878A2 Sterilization of corticosteroids with reduced mass loss |
| 11/12/2008 | EP1988877A2 Therapeutic compositions comprising ingenol-3-angelate |
| 11/12/2008 | EP1988876A2 Nebulizer formulation |
| 11/12/2008 | EP1988875A2 Modified release formulation |